Pharmacokinetics and side effects of interferon in man
Merigan, T.C.
Texas Reports on Biology and Medicine 35: 541-547
1977
ISSN/ISBN: 0040-4675 PMID: 358475 Document Number: 118510
Document emailed within 1 workday
Related Documents
Vial, T.; Bailly, F.; Descotes, J.; Trepo, C. 1996: Side effects of interferon-alpha Gastroenterologie Clinique et Biologique 20(5): 462-489Kaspar, U. 1976: Diphenylhydantoin. Metabolism, pharmacokinetics, interactions and side effects Schweizerische Medizinische Wochenschrift 106(23): 777-788
Arase, Y. 2006: Side effects of interferon therapy for chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 64(7): 1363-1367
Chang, L.W.; Liranzo, M.; Bergfeld, W.F. 1995: Cutaneous side effects associated with interferon-alpha therapy: a review Cutis 56(3): 144
Huber, M. 1988: Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results Der Nervenarzt 59(9): 514-520
Kuwabara, Y.; Komuro, I. 2007: ACE inhibitor: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 66-73
Rostaing, L.; Izopet, J.; Baron, E.; Duffaut, M.; Puel, J.; Durand, D. 1995: Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects Transplantation Proceedings 27(1): 948-950
Pander Maat, H.; Klaassen, R. 1996: The effect of the wording of information about side effects on patients' interpretation of reported side effects Nederlands Tijdschrift Voor Geneeskunde 140(8): 424-427
Britton, S. 2013: Vaccines must have a minimal amount of side effects. Serious side effects threatens public trust Lakartidningen 110(16): 816
Yamasaki, T.; Kagawa, T.; Takamura, M.; Moritake, K. 1995: Pharmacokinetics of intratumoral interferon-gamma activity following subcutaneous administration of recombinant interferon-gamma in a patient with metastatic brain tumor derived from renal cancer No Shinkei Geka. Neurological Surgery 23(2): 169-173
Dinbar, A.; Fonkalsrud, E.W. 1971: Enzmatic and histologic effects of side-to-side portacaval anastomosis on the primate liver Surgery Gynecology and Obstetrics 133(1): 35-38
Tazulakhova, E.B.; Amitina, N.N.; Ershov, F.I. 1985: Interferon-inducing and antiviral effects of inosiplex in combination with high-molecular interferon inducers Biulleten' Eksperimental'noi Biologii i Meditsiny 100(10): 457-459
Koyama, S.; Narita, M. 1988: In vitro effects of interferon-alpha and interferon-gamma on hematopoietic progenitor cells in bone marrow Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1540-1549
Sayers, T.J.; Wiltrout, T.A.; McCormick, K.; Husted, C.; Wiltrout, R.H. 1990: Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo Cancer Research 50(17): 5414-5420
Greene, J. 2002: Side by side. Communication is key to a successful side by side CEO-board chair partnership Trustee: the Journal for Hospital Governing Boards 55(5): 6
Gomi, K.; Morimoto, M.; Inoue, A.; Kobayashi, H.; Deguchi, T.; Hara, T.; Nakamizo, N. 1984: Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits Gan 75(3): 292-300
Greischel, A.; Tanswell, P.; Busch, U.; Schumacher, K. 1988: Pharmacokinetics and biodisposition of recombinant human interferon-alpha 2C in rat and marmoset Arzneimittel-Forschung 38(10): 1539-1543
Gopalan, S.S.; Mutasa, R.; Friedman, J.; Das, A. 2014: Health sector demand-side financial incentives in low- and middle-income countries: a systematic review on demand- and supply-side effects Social Science and Medicine 100: 72-83
Brockmeyer, N.H.; Mertins, L.; Spatz, D.; Tillmann, I.; Goos, M. 1992: Endogenous interferon plasma levels and antipyrine pharmacokinetics in patients with viral infections International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 530-533
Nagao, S.; Nakano, A.; Moritake, K.; Morikawa, S.; Harada, T. 1997: Synergistic antitumor effects of human interferon-beta and interferon-gamma on human gastric adenocarcinoma cells Human Cell 10(1): 95-104